Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa Ferretti

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Oncoimmunology|July 7, 2017
MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastomaElisa Brandetti, Irene Veneziani, Ombretta Melaiu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2004
CCL19 and CXCL12 trigger in vitro chemotaxis of human mantle cell lymphoma B cellsAnna Corcione, Nicoletta Arduino, Elisa Ferretti, et al.
Plos One|December 31, 2009
CX3CR1 is expressed by human B lymphocytes and mediates [corrected] CX3CL1 driven chemotaxis of tonsil centrocytesAnna Corcione, Elisa Ferretti, Maria Bertolotto, et al.
British Journal of Haematology|July 28, 2012
Etanercept treatment in Fanconi anaemia; combined US and Italian experienceParinda A Mehta, Johanna Svahn, Stella M Davies, et al.
Oncotarget|November 22, 2017
Interleukin-31 and thymic stromal lymphopoietin expression in plasma and lymph node from Hodgkin lymphoma patientsElisa Ferretti, Stefan Hohaus, Arianna Di Napoli, et al.
Oncoimmunology|October 10, 2015
Interleukin-17A promotes the growth of human germinal center derived non-Hodgkin B cell lymphomaElisa Ferretti, Emma Di Carlo, Emanuela Ognio, et al.
Haematologica|July 10, 2009
Changes in cytokine profile pre- and post-immunosuppression in acquired aplastic anemiaCarlo Dufour, Elisa Ferretti, Francesca Bagnasco, et al.
Cancer Immunology Research|December 11, 2020
Nutlin-3a Enhances Natural Killer Cell-Mediated Killing of Neuroblastoma by Restoring p53-Dependent Expression of Ligands for NKG2D and DNAM-1 ReceptorsIrene Veneziani, Paola Infante, Elisa Ferretti, et al.
Small (Weinheim an Der Bergstrasse, Germany)|April 24, 2020
Combined Replenishment of miR-34a and let-7b by Targeted Nanoparticles Inhibits Tumor Growth in Neuroblastoma Preclinical ModelsDaniela Di Paolo, Fabio Pastorino, Chiara Brignole, et al.
Frontiers in Immunology|July 3, 2025
Colorectal cancer-infiltrating NK cell landscape analysis unravels tissue-resident PD-1<sup>+</sup> NK cells in microsatellite instability tumorsValentina Obino, Chiara Giordano, Simona Carlomagno, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Oncoimmunology|July 7, 2017
MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastomaElisa Brandetti, Irene Veneziani, Ombretta Melaiu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2004
CCL19 and CXCL12 trigger in vitro chemotaxis of human mantle cell lymphoma B cellsAnna Corcione, Nicoletta Arduino, Elisa Ferretti, et al.
Plos One|December 31, 2009
CX3CR1 is expressed by human B lymphocytes and mediates [corrected] CX3CL1 driven chemotaxis of tonsil centrocytesAnna Corcione, Elisa Ferretti, Maria Bertolotto, et al.
British Journal of Haematology|July 28, 2012
Etanercept treatment in Fanconi anaemia; combined US and Italian experienceParinda A Mehta, Johanna Svahn, Stella M Davies, et al.
Oncotarget|November 22, 2017
Interleukin-31 and thymic stromal lymphopoietin expression in plasma and lymph node from Hodgkin lymphoma patientsElisa Ferretti, Stefan Hohaus, Arianna Di Napoli, et al.
Oncoimmunology|October 10, 2015
Interleukin-17A promotes the growth of human germinal center derived non-Hodgkin B cell lymphomaElisa Ferretti, Emma Di Carlo, Emanuela Ognio, et al.
Haematologica|July 10, 2009
Changes in cytokine profile pre- and post-immunosuppression in acquired aplastic anemiaCarlo Dufour, Elisa Ferretti, Francesca Bagnasco, et al.
Cancer Immunology Research|December 11, 2020
Nutlin-3a Enhances Natural Killer Cell-Mediated Killing of Neuroblastoma by Restoring p53-Dependent Expression of Ligands for NKG2D and DNAM-1 ReceptorsIrene Veneziani, Paola Infante, Elisa Ferretti, et al.
Small (Weinheim an Der Bergstrasse, Germany)|April 24, 2020
Combined Replenishment of miR-34a and let-7b by Targeted Nanoparticles Inhibits Tumor Growth in Neuroblastoma Preclinical ModelsDaniela Di Paolo, Fabio Pastorino, Chiara Brignole, et al.
Frontiers in Immunology|July 3, 2025
Colorectal cancer-infiltrating NK cell landscape analysis unravels tissue-resident PD-1<sup>+</sup> NK cells in microsatellite instability tumorsValentina Obino, Chiara Giordano, Simona Carlomagno, et al.
Pageof 3